Mathieu Beaulieu

Summary

Country: Canada

Publications

  1. ncbi Risk of Clostridium difficile-associated disease among patients receiving proton-pump inhibitors in a Quebec medical intensive care unit
    Mathieu Beaulieu
    Faculty of Pharmacy, Universite de Montreal, Montreal, QC, H3C 3J7, Canada
    Infect Control Hosp Epidemiol 28:1305-7. 2007
  2. ncbi Do proton-pump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit?
    Mathieu Beaulieu
    Faculty of Pharmacy, Universite de Montreal, Hopital du Sacre Coeur de Montreal, Quebec, Canada
    J Crit Care 23:513-8. 2008
  3. ncbi Systematic review of pharmacoeconomic studies of pharmacogenomic tests
    Mathieu Beaulieu
    Faculte de Pharmacie, Universite de Montreal, PO Box 6128, Succ Centre Ville, Montreal, Quebec, H3C 3J7, Canada
    Pharmacogenomics 11:1573-90. 2010
  4. ncbi Clostridium difficile-associated diarrhea outbreaks: the name of the game is isolation and cleaning
    Mathieu Beaulieu
    Clin Infect Dis 42:725; author reply 727-9. 2006

Collaborators

Detail Information

Publications4

  1. ncbi Risk of Clostridium difficile-associated disease among patients receiving proton-pump inhibitors in a Quebec medical intensive care unit
    Mathieu Beaulieu
    Faculty of Pharmacy, Universite de Montreal, Montreal, QC, H3C 3J7, Canada
    Infect Control Hosp Epidemiol 28:1305-7. 2007
    ..Our findings suggest that efforts to determine risk factors for CDAD should focus on other areas, such as older age and antibiotic use...
  2. ncbi Do proton-pump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit?
    Mathieu Beaulieu
    Faculty of Pharmacy, Universite de Montreal, Hopital du Sacre Coeur de Montreal, Quebec, Canada
    J Crit Care 23:513-8. 2008
    ..The aim of this study was to determine whether the use of gastric acid-suppressive agents increases the risk of nosocomial pneumonia (NP) in a medical intensive care unit population...
  3. ncbi Systematic review of pharmacoeconomic studies of pharmacogenomic tests
    Mathieu Beaulieu
    Faculte de Pharmacie, Universite de Montreal, PO Box 6128, Succ Centre Ville, Montreal, Quebec, H3C 3J7, Canada
    Pharmacogenomics 11:1573-90. 2010
    ..In order to fully assess all aspects of pharmacogenomic testing, future pharmacoeconomic assessments should include every specific component that has an impact on the incremental cost-effectiveness ratio...
  4. ncbi Clostridium difficile-associated diarrhea outbreaks: the name of the game is isolation and cleaning
    Mathieu Beaulieu
    Clin Infect Dis 42:725; author reply 727-9. 2006